NO893071D0 - Fremgangsmaate ved fremstilling av lys-plasminogen. - Google Patents

Fremgangsmaate ved fremstilling av lys-plasminogen.

Info

Publication number
NO893071D0
NO893071D0 NO893071A NO893071A NO893071D0 NO 893071 D0 NO893071 D0 NO 893071D0 NO 893071 A NO893071 A NO 893071A NO 893071 A NO893071 A NO 893071A NO 893071 D0 NO893071 D0 NO 893071D0
Authority
NO
Norway
Prior art keywords
plasminogen
lys
mol
protein
hours
Prior art date
Application number
NO893071A
Other languages
English (en)
Other versions
NO175260B (no
NO893071L (no
NO175260C (no
Inventor
Yenda Linnau
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of NO893071D0 publication Critical patent/NO893071D0/no
Publication of NO893071L publication Critical patent/NO893071L/no
Publication of NO175260B publication Critical patent/NO175260B/no
Publication of NO175260C publication Critical patent/NO175260C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO893071A 1988-07-28 1989-07-27 Fremgangsmåte ved fremstilling av lys-plasminogen NO175260C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0191988A AT390801B (de) 1988-07-28 1988-07-28 Verfahren zur herstellung von lys-plasminogen

Publications (4)

Publication Number Publication Date
NO893071D0 true NO893071D0 (no) 1989-07-27
NO893071L NO893071L (no) 1990-01-29
NO175260B NO175260B (no) 1994-06-13
NO175260C NO175260C (no) 1994-09-21

Family

ID=3523862

Family Applications (1)

Application Number Title Priority Date Filing Date
NO893071A NO175260C (no) 1988-07-28 1989-07-27 Fremgangsmåte ved fremstilling av lys-plasminogen

Country Status (10)

Country Link
US (2) US5371007A (no)
EP (1) EP0353218B1 (no)
JP (1) JP2521354B2 (no)
AT (2) AT390801B (no)
CA (1) CA1334079C (no)
DE (1) DE58901530D1 (no)
DK (1) DK371689A (no)
ES (1) ES2043113T3 (no)
FI (1) FI93518C (no)
NO (1) NO175260C (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390801B (de) * 1988-07-28 1990-07-10 Immuno Ag Verfahren zur herstellung von lys-plasminogen
US4989922A (en) * 1988-11-23 1991-02-05 Lucas Industries Public Limited Company Method of anti-lock brake control for motorcycle vehicle
AT402367B (de) * 1990-10-11 1997-04-25 Immuno Ag Pharmazeutische zubereitung auf basis von lys-plasminogen
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
WO1994013329A1 (de) * 1992-12-16 1994-06-23 Immuno Aktiengesellschaft Verfahren zur herstellung eines virussicheren biologischen präparates
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5520912A (en) * 1993-07-02 1996-05-28 Immuno Aktiengesellschaft Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen
JPH0739375A (ja) * 1993-07-29 1995-02-10 Green Cross Corp:The プラスミノーゲンの精製方法
DE4411143C2 (de) * 1994-03-30 1996-08-01 Immuno Ag Thrombosemittel
US6068838A (en) * 1996-04-29 2000-05-30 Baxter Aktiengesellschaft Purified multimerase
US6207066B1 (en) 1996-07-23 2001-03-27 Nuvue Technologies, L.L.C. Method for purification of a blood component
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US6964764B2 (en) 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6969515B2 (en) * 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6855263B2 (en) 2002-07-23 2005-02-15 Nuvue Technologies, Inc. Rapid process for purification and concentration of plasmin
CN1303413C (zh) * 2003-06-17 2007-03-07 余伟明 蛋白质、病毒快速富集方法
US8617863B2 (en) * 2008-06-04 2013-12-31 Grifols Therapeutics Inc. Composition, method, and kit for preparing plasmin
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT390801B (de) * 1988-07-28 1990-07-10 Immuno Ag Verfahren zur herstellung von lys-plasminogen

Also Published As

Publication number Publication date
EP0353218A3 (en) 1990-05-16
ES2043113T3 (es) 1993-12-16
JP2521354B2 (ja) 1996-08-07
FI893519A0 (fi) 1989-07-21
DK371689D0 (da) 1989-07-27
FI93518C (fi) 1995-04-25
JPH0297386A (ja) 1990-04-09
FI93518B (fi) 1995-01-13
FI893519A (fi) 1990-01-29
US5556766A (en) 1996-09-17
NO175260B (no) 1994-06-13
AT390801B (de) 1990-07-10
NO893071L (no) 1990-01-29
CA1334079C (en) 1995-01-24
ATE76578T1 (de) 1992-06-15
EP0353218B1 (de) 1992-05-27
US5371007A (en) 1994-12-06
NO175260C (no) 1994-09-21
DE58901530D1 (de) 1992-07-02
EP0353218A2 (de) 1990-01-31
DK371689A (da) 1990-01-29
ATA191988A (de) 1989-12-15

Similar Documents

Publication Publication Date Title
NO893071L (no) Fremgangsmaate ved fremstilling av lys-plasminogen.
EP0102216A2 (en) Biosynthesis of unnatural cephalosporins
DK0625571T3 (da) Mikroorganismer, deres anvendelse samt fremgangsmåde til fremstilling af L-alfa-aminosyrer
EP0366303A3 (en) Biocatalysts
IL95090A0 (en) Improved enzymatic oxidation of ceph c to glutaryl-7-amino-cephalosporanic acid
DK506683A (da) Fibrinolytiske enzymer, fremgangsmaader til fremstilling deraf og farmaceutiske midler indeholdende dem
AU4871993A (en) Dictyostelium dipeptidylaminopeptidase
Kivirikko et al. Asymmetry in the hydroxylation of (Pro-Pro-Gly) 5 by protocollagen proline hydroxylase
NO893643L (no) Fremgangsmaate for oekning av enzymaktivitet og syntesekapasitet av organismer.
EP0420562A1 (en) Deacetoxycephalosporin C hydroxylase
EP0201800A3 (en) A cholesterol-rich fraction, process therefor and use thereof in cell culture
EP0316907A3 (en) Enzyme inhibitor and method of producing the same
JPS6443192A (en) Dna having genetic information on sarcosine oxidase and use thereof
HUT52018A (en) Process for production of biohumus with culture of manure-worm
ES8604973A1 (es) Un procedimiento para la preparacion de penicilina v.
ES8604974A1 (es) Un procedimiento para la fabricacion de penicilina g.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003